These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 329981
1. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU. Einhorn LH, Furnas B. Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981 [Abstract] [Full Text] [Related]
2. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma. Ahmann DL, Hahn RG, Bisel HF, Eagan RT, Edmonson JH. Cancer Chemother Rep; 1975 Aug; 59(2 Pt 1):451-3. PubMed ID: 1097102 [No Abstract] [Full Text] [Related]
3. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065). Carter RD, Krementz ET, Hill GJ, Metter GE, Fletcher WS, Golomb FM, Grage TB, Minton JP, Sparks FC. Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149 [Abstract] [Full Text] [Related]
4. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma]. Kogoniia LM, Moroz LV, Perevodchikova NI, Platinskiĭ LV, Borisov AI. Vopr Onkol; 1981 May; 27(4):16-21. PubMed ID: 7015692 [Abstract] [Full Text] [Related]
5. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy. Everall JD, Dowd PM. Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710 [No Abstract] [Full Text] [Related]
6. Results with methyl-CCNU and DTIC in metastatic melanoma. Costanza ME, Nathanson L, Schoenfeld D, Wolter J, Colsky J, Regelson W, Cunningham T, Sedransk N. Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319 [Abstract] [Full Text] [Related]
7. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma. Ahmann DL, Bisel HF, Edmonson JH, Hahn RG, Eagan RT, O'Connell MJ, Frytak S. Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589 [Abstract] [Full Text] [Related]
8. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM. Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [Abstract] [Full Text] [Related]
9. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma. Cohen MH, Schoenfeld D, Wolter J. Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102 [Abstract] [Full Text] [Related]
10. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma. Bellett RE, Mastrangelo MJ, Laucius JF, Bodurtha AJ. Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478 [Abstract] [Full Text] [Related]
11. Influence of therapy on the antioxidant status in patients with melanoma. Gadjeva V, Dimov A, Georgieva N. J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784 [Abstract] [Full Text] [Related]
12. [Treatment of metastatic malignant melanoma (author's transl)]. Kühböck J, Pehamberger H, Mach K, Diem E, Kokoschka EM, Pötzi P. Wien Klin Wochenschr; 1978 Dec 22; 90(24):856-8. PubMed ID: 84441 [Abstract] [Full Text] [Related]
13. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine. Carmo-Pereira J, Oliveira Costa F, Pimentel P. Cancer Treat Rep; 1976 Sep 22; 60(9):1381-3. PubMed ID: 1016972 [No Abstract] [Full Text] [Related]
14. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M, Neuber K, Bieber T, Gilde K, Guillem Porta V, Fra J, Bonneterre J, Saïag P, Kamanabrou D, Pehamberger H, Sufliarsky J, Gonzalez Larriba JL, Scherrer A, Menu Y. J Clin Oncol; 2004 Mar 15; 22(6):1118-25. PubMed ID: 15020614 [Abstract] [Full Text] [Related]
15. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma. Samson MK, Baker LH, Talley RW, Fraile RJ, McDonald B. Cancer Treat Rep; 1978 Aug 15; 62(8):1223-5. PubMed ID: 356980 [Abstract] [Full Text] [Related]
16. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group. Cancer; 1989 May 01; 63(9):1676-80. PubMed ID: 2467736 [Abstract] [Full Text] [Related]
17. DTIC (NSC-45388) studies in the southwest oncology group. Costanzi JJ. Cancer Treat Rep; 1976 Feb 01; 60(2):189-92. PubMed ID: 769972 [Abstract] [Full Text] [Related]
18. DTIC (NSC-45388) in malignant melanoma: a perspective. Comis RL. Cancer Treat Rep; 1976 Feb 01; 60(2):165-76. PubMed ID: 769969 [No Abstract] [Full Text] [Related]
19. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma. De Wasch G, Bernheim J, Michel J, Lejeune F, Kenis Y. Cancer Treat Rep; 1976 Sep 01; 60(9):1273-6. PubMed ID: 65222 [Abstract] [Full Text] [Related]
20. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma. Van Dyk JJ, Falkson G. Med Pediatr Oncol; 1975 Sep 01; 1(2):107-11. PubMed ID: 1228411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]